Most Recent
Motorola has urged the High Court to reject Hytera's special leave application in their long-running dispute over the theft of Motorola's source code for its digital mobile radios.
The Full Federal Court has published its reasons for finding Hytera copied a substantial part of Motorola's source code for its digital mobile radios, saying the 15 months of labour the China-based company saved from the copying reinforced its conclusion.
Swiss pharmaceutical company Actelion has brought a fourth patent infringement case over plans to launch a generic version of its blood pressure drug in Australia -- against Lupin unit Generic Health -- after firing off cases against three other drug makers.
Engineering group Sandvik Mining and Construction has prevailed in defence of a patent application for rotary drill technology used for underground mining.
Cipla Australia wants an undertaking it intends to give pharma company Actelion over plans to launch a generic version of a blood pressure drug to be shielded from rivals Arrotex, Nova Pharmaceuticals and MSN Laboratories, as those companies battle patent infringement claims.
US-based medical device maker OrthAlign has lost its lawsuit alleging Sydney-based surgical technology company Navbit infringed its patent for a technology used to guide the positioning of artificial hip joints during surgery.
China-based Hytera Communications wants the High Court to overturn a finding that it stole Motorola's source code for its digital mobile radios, arguing the appeal raises important issues about how "substantial part" should be assessed under the Copyright Act.
A trade mark dispute between US singer Katy Perry and an Australian fashion designer is back in court for a fight on damages and injunctions, after the designer secured a win before the High Court in March.
Cement Australia has appealed a decision allowing Boral to amend its patent for a lower carbon cement, after losing its argument that the changes would broaden the scope of the patent.
Industry standards group Meat & Livestock Australia can bring a cross-claim for indemnity against the Agricultural Business Research Institute while defending a case alleging it infringed a patent for inferring bovine gene traits.